Home » Medical Devices » Vietnam Cardiovascular Devices Market

Vietnam Cardiovascular Devices Market

Vietnam Cardiovascular Devices Market By Product (Diagnostic & Monitoring Devices, Surgical Devices); By End User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others); By Diagnostic & Monitoring Devices Type (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Others); By Surgical Devices Type (Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Coronary Stents, Catheters); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Vietnam Cardiovascular Devices Market Size 2024	USD202.06 million
Vietnam Cardiovascular Devices Market, CAGR	7.7%
Vietnam Cardiovascular Devices Market Size 2032	USD395.32 million

Market Overview

The Vietnam Cardiovascular Devices Market is projected to grow from USD202.06 million in 2024 to an estimated USD395.32 million by 2032, with a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032. This growth is driven by increasing healthcare investments, a rising burden of cardiovascular diseases, and advancements in medical technology.

Several key drivers are contributing to the market’s expansion. These include the increasing prevalence of cardiovascular diseases due to lifestyle changes, an aging population, and the rising awareness of heart health. Additionally, the country is witnessing improvements in healthcare infrastructure and increased accessibility to medical technologies. The demand for minimally invasive procedures, along with innovations in device technologies, is also helping to propel market growth.

Geographically, Vietnam’s cardiovascular devices market is expanding rapidly, with key players such as Philips Healthcare, GE Healthcare, and Medtronic being prominent contributors. These companies are focused on offering advanced cardiovascular solutions to meet the growing healthcare needs of the country. With urbanization and healthcare reforms continuing to drive the market, Vietnam’s cardiovascular device sector is poised for significant development over the coming years.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Vietnam cardiovascular devices market is expected to grow from USD202.06 million in 2024 to USD395.32 million by 2032, with a CAGR of 7.7% from 2025 to 2032. The market growth is supported by advancements in medical technologies and increasing healthcare investments.
The global cardiovascular devices market is projected to grow from USD 72,115.60 million in 2024 to USD 133,700.94 million by 2032, with a CAGR of 7.1% from 2025 to 2032, driven by increasing cardiovascular diseases and advancements in medical technology.
Key drivers include the rising prevalence of cardiovascular diseases, an aging population, increasing healthcare investments, and greater access to advanced medical technologies, leading to higher demand for diagnostic and therapeutic devices.
High costs of advanced cardiovascular devices and limited reimbursement policies may act as restraints, particularly in rural areas where access to such technologies remains challenging.
Continual advancements in minimally invasive devices, diagnostic imaging systems, and wearable health monitors are driving market growth by improving treatment outcomes and patient recovery times.
Southern Vietnam leads the market, driven by strong urban healthcare infrastructure, with growing demand in the northern and central regions due to government healthcare reforms and improved access.
Ongoing improvements in Vietnam’s healthcare infrastructure are contributing to increased adoption of cardiovascular devices, particularly in urban and peri-urban areas.
As public awareness about cardiovascular diseases increases, more individuals are seeking early diagnosis and preventive care, leading to higher demand for advanced diagnostic tools.

Report Scope

This report segments the Vietnam Cardiovascular Devices Market as follows:

Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The growing incidence of cardiovascular diseases (CVDs) in Vietnam is one of the primary factors driving the demand for cardiovascular devices. CVDs, including coronary artery diseases, heart attacks, strokes, and heart failure, are becoming more prevalent due to several risk factors such as unhealthy diets, sedentary lifestyles, high levels of smoking, and increasing levels of stress in the population. According to the World Health Organization (WHO), for instance, cardiovascular diseases accounted for approximately 170,000 deaths in Vietnam in 2016 in Viet Nam – World Health Organization (WHO). The prevalence of hypertension among adults aged 18-69 years is 18.9%, with only 13.6% of hypertensive patients receiving treatment at healthcare facilities in Viet Nam – World Health Organization (WHO). The rising incidence of these diseases is compelling both public and private healthcare sectors to invest in advanced cardiovascular technologies that improve diagnosis, monitoring, and treatment. Consequently, there is a higher demand for devices such as pacemakers, defibrillators, diagnostic imaging systems, and stents, all of which are essential in the effective management of heart diseases. With an aging population and urbanization further exacerbating risk factors, the demand for cardiovascular devices is set to rise, making it one of the most significant drivers in the market.

Government Support and Healthcare Reforms

The Vietnamese government has been increasingly proactive in improving the healthcare infrastructure and making healthcare services more accessible to the population. The government has introduced several reforms aimed at enhancing the healthcare system, including the expansion of health insurance coverage, which ensures that more people have access to essential medical treatments, including cardiovascular care. As part of its healthcare modernization efforts, Vietnam is also focusing on improving medical technology and adopting advanced medical devices. For instance, Vietnam has seen a rise in the adoption of AI-driven diagnostic tools and remote monitoring systems for cardiovascular patients. This focus on healthcare infrastructure and regulatory support is fostering the growth of the cardiovascular devices market. Notably, the government’s commitment to addressing the burden of chronic diseases like cardiovascular disorders has led to enhanced investments in hospitals and healthcare institutions across the country. Such initiatives will not only increase the availability of cardiovascular devices but also promote technological adoption and improve healthcare delivery standards nationwide. For instance, Vietnam’s healthcare sector has integrated robotic-assisted cardiovascular procedures to enhance precision and patient outcomes. As a result, more healthcare facilities will be equipped with modern cardiovascular diagnostic and treatment devices, further supporting the growth of the market.

Technological Advancements in Cardiovascular Devices

The ongoing advancements in cardiovascular device technology are another major driver of market growth. Modern cardiovascular devices are becoming increasingly sophisticated, offering better precision, enhanced functionality, and improved patient outcomes. For instance, the development of minimally invasive devices, including catheter-based interventions for coronary artery diseases, has revolutionized heart disease treatment by reducing the need for major surgeries and facilitating faster recovery times. Additionally, advancements in diagnostic imaging technologies such as echocardiography, MRI, and CT scans allow for earlier detection of cardiovascular conditions, which is critical for successful interventions. The continuous innovations in device technologies, such as drug-eluting stents, wearable heart monitors, and implantable cardioverter-defibrillators (ICDs), are improving treatment efficiency, reducing healthcare costs, and enabling personalized care. As healthcare providers and medical professionals become more familiar with these cutting-edge technologies, the demand for advanced cardiovascular devices in Vietnam is expected to rise significantly. Furthermore, the growing adoption of telemedicine and digital health solutions also provides a more convenient and effective method for patients and doctors to monitor cardiovascular health, contributing further to the expansion of the cardiovascular devices market in Vietnam.

Rising Health Awareness and Consumer Demand for Quality Healthcare

There has been a noticeable shift in the public’s health awareness in Vietnam, particularly with regard to heart health and the importance of regular cardiovascular check-ups. Increased access to information through digital platforms, social media, and healthcare campaigns has helped to educate the population about the risks associated with poor lifestyle choices, such as unhealthy diets and lack of physical activity. As awareness increases, more individuals are seeking proactive and preventive healthcare solutions, including regular cardiovascular screenings and early diagnostic tests. This growing awareness, combined with the increasing willingness to invest in healthcare, has led to a higher demand for quality cardiovascular devices. As a result, both the private and public healthcare sectors are under pressure to offer advanced treatment options, driving further demand for state-of-the-art medical devices. Additionally, as the country’s middle-class population expands, there is a growing demand for more advanced healthcare services, which further supports the market for high-end cardiovascular devices such as coronary stents, pacemakers, and diagnostic imaging systems. This trend is expected to continue as the population becomes more health-conscious, fostering an environment where cardiovascular device adoption will flourish.

Market Trends

Adoption of Minimally Invasive Devices

In Vietnam, the trend toward minimally invasive procedures for cardiovascular treatments is gaining momentum. Minimally invasive devices, such as catheter-based interventions, stents, and balloon angioplasty systems, are increasingly preferred due to their ability to reduce recovery time, minimize surgical risks, and lower healthcare costs. These devices enable doctors to perform complex procedures with smaller incisions, leading to quicker recovery and shorter hospital stays for patients. For instance, hospitals in Ho Chi Minh City and Hanoi have expanded their use of robotic-assisted catheter procedures to enhance precision and patient outcomes. Additionally, Vietnam’s healthcare sector is seeing increased investment in hybrid operating rooms that integrate real-time imaging with interventional cardiology, improving procedural accuracy and efficiency. With the growing focus on patient comfort and faster recovery times, both patients and healthcare providers are gravitating toward these advanced technologies. Furthermore, the government’s ongoing push to modernize healthcare infrastructure is facilitating the adoption of these cutting-edge technologies in both public and private healthcare facilities. As more hospitals and clinics are equipped with state-of-the-art cardiovascular devices, the demand for minimally invasive tools will continue to rise, shaping the future landscape of cardiovascular care in Vietnam.

Rise of Digital Health Solutions and Remote Monitoring

Digital health solutions, including remote monitoring tools, telemedicine, and wearable cardiovascular devices, are emerging as significant trends in Vietnam’s healthcare sector. With the advancement of IoT (Internet of Things) and AI technologies, wearable devices such as smartwatches and heart rate monitors are now equipped with advanced cardiovascular tracking features. These devices allow patients to continuously monitor their heart health, alerting them to potential risks and enabling timely interventions. For instance, AI-powered ECG analysis tools are now being deployed in Vietnamese hospitals to enhance diagnostic accuracy and streamline patient management. Additionally, healthcare providers are leveraging telemedicine platforms to conduct virtual consultations and monitor patients remotely, particularly in rural areas where access to specialized care may be limited. For instance, government-backed telemedicine initiatives are expanding digital health infrastructure to improve accessibility. This digital transformation is driving the demand for remote monitoring devices, offering convenience to both patients and healthcare professionals while also reducing the need for in-person visits, thus improving overall healthcare accessibility and efficiency.

Increasing Focus on Preventive Cardiovascular Care

There is a growing shift in Vietnam towards preventive cardiovascular care, as healthcare professionals and institutions emphasize the importance of early diagnosis and lifestyle management. As cardiovascular diseases are largely preventable, many healthcare providers are focusing on education, awareness campaigns, and screenings to detect risk factors such as high blood pressure, diabetes, and high cholesterol levels early. This trend is driving the demand for diagnostic devices like ECGs, blood pressure monitors, and cholesterol testing equipment. With an aging population and increasing urbanization, the government and private healthcare providers are investing in regular screenings and health check-up packages to detect cardiovascular conditions at an early stage. The emphasis on prevention is gradually shaping the market by encouraging patients to prioritize regular check-ups and take preventive actions, boosting the demand for cardiovascular diagnostic devices in the process.

Rising Demand for Advanced Cardiac Monitoring Systems

Cardiac monitoring systems are experiencing increased demand in Vietnam, reflecting the growing need for real-time data to manage cardiovascular conditions effectively. Hospitals and healthcare providers are integrating advanced cardiac monitoring technologies, including electrocardiogram (ECG) devices, Holter monitors, and implantable loop recorders, to track heart rhythms and detect arrhythmias, heart attacks, and other critical cardiovascular conditions. These systems offer healthcare professionals the ability to monitor patients’ cardiac health continuously and make timely interventions. The trend toward advanced cardiac monitoring is also driven by the increasing prevalence of heart disease, the rise in healthcare spending, and the adoption of telemedicine platforms, which allow for remote monitoring and data analysis. The integration of cloud-based solutions and AI in cardiac monitoring systems further enhances diagnostic accuracy, making these devices a key component of Vietnam’s evolving cardiovascular care landscape. As patients seek more efficient and comprehensive care, the demand for these advanced monitoring solutions is expected to continue growing.

Market Challenges

High Costs and Affordability Issues

One of the significant challenges facing the Vietnam cardiovascular devices market is the high cost of advanced cardiovascular technologies. Many cutting-edge devices, such as stents, pacemakers, and diagnostic imaging systems, come with substantial price tags that limit their affordability, particularly in lower-income segments of the population. Although Vietnam has made significant strides in improving its healthcare infrastructure, the disparity in healthcare access between urban and rural areas continues to be a concern. In rural regions, the cost of medical devices remains a barrier, and many healthcare facilities cannot afford the latest technology. This issue is compounded by limited reimbursement schemes and inadequate health insurance coverage for advanced cardiovascular treatments. For instance, Vietnam has seen increased adoption of minimally invasive cardiovascular procedures, but rural hospitals struggle with implementation due to financial constraints. As a result, patients who need these devices may face financial challenges, leading to delayed treatments or reliance on less advanced alternatives. In 2024, Vietnamese medical technology firms introduced portable echocardiography devices designed for use in remote clinics, aiming to enhance early detection of cardiovascular diseases in underserved regions. To overcome this challenge, both the private and public sectors must work toward making cardiovascular devices more affordable through government subsidies, insurance reforms, and strategic partnerships with manufacturers to lower the costs of these life-saving technologies.

Limited Skilled Healthcare Workforce

Another critical challenge in the Vietnamese cardiovascular devices market is the shortage of highly trained medical professionals skilled in operating advanced cardiovascular devices. While the healthcare system is improving, the country still faces a shortage of specialized cardiologists, cardiovascular surgeons, and technicians who are proficient in using the latest diagnostic and treatment devices. The complexity of modern cardiovascular devices requires extensive training and expertise to ensure effective use. In some cases, healthcare providers may not have the necessary skills or knowledge to maximize the capabilities of new technologies, potentially leading to suboptimal patient outcomes. This challenge is particularly pronounced in rural and remote areas, where specialized training is less accessible. The lack of a sufficiently skilled workforce limits the overall effectiveness of the cardiovascular care system and hampers the widespread adoption of advanced devices. To address this issue, Vietnam needs to invest in healthcare workforce development programs, such as specialized training and certification for healthcare professionals, to ensure they are equipped with the skills necessary to operate modern cardiovascular devices effectively.

Market Opportunities

Expansion of Private Healthcare Sector

One of the key opportunities in the Vietnam cardiovascular devices market lies in the continued growth of the private healthcare sector. As Vietnam’s middle class expands and disposable incomes rise, there is an increasing demand for high-quality healthcare services. Private hospitals and clinics are better equipped to offer advanced diagnostic and therapeutic solutions, making them key players in the adoption of sophisticated cardiovascular devices. The expansion of private healthcare infrastructure, especially in urban centers like Ho Chi Minh City and Hanoi, presents a significant opportunity for device manufacturers to meet the growing demand for cutting-edge cardiovascular technologies. Moreover, as more private healthcare providers compete to attract affluent patients, they are likely to invest in state-of-the-art equipment, further driving the need for advanced cardiovascular devices. This trend also creates opportunities for partnerships between device manufacturers and private healthcare institutions to enhance care delivery and market penetration.

Government Initiatives to Modernize Healthcare

Another significant opportunity is the Vietnamese government’s commitment to modernizing the healthcare system. Through initiatives aimed at expanding healthcare coverage, improving infrastructure, and enhancing the quality of medical services, there is a growing focus on reducing the burden of cardiovascular diseases. The government has increased investments in upgrading public hospitals, especially in terms of equipping them with advanced medical technologies, including cardiovascular devices. Additionally, the introduction of policies to make healthcare more affordable and accessible to a larger population offers an opportunity for the growth of the cardiovascular devices market. Public-private partnerships, along with increased funding for healthcare reforms, present an ideal environment for both local and international cardiovascular device manufacturers to expand their presence in the market and contribute to the modernization of the healthcare sector.

Market Segmentation Analysis

By Product

The Vietnam cardiovascular devices market is primarily segmented into two key categories: diagnostic and monitoring devices, and surgical devices. Diagnostic and monitoring devices include a variety of equipment used to assess and monitor cardiovascular health, such as electrocardiograms (ECG), echocardiography machines, blood pressure monitors, and Holter monitors. These devices are crucial for early detection, diagnosis, and monitoring of cardiovascular conditions, allowing healthcare providers to offer timely interventions. The growing prevalence of cardiovascular diseases, along with increasing health awareness, has led to a rising demand for these diagnostic tools. On the other hand, surgical devices include pacemakers, defibrillators, coronary stents, and surgical instruments used in cardiovascular procedures. These devices are essential for treating existing cardiovascular conditions and providing life-saving interventions. As the technology improves, surgical devices are becoming more advanced, offering better outcomes, quicker recovery times, and less invasive procedures. The demand for both diagnostic and surgical devices continues to grow, driven by the increasing burden of cardiovascular diseases and advancements in medical technologies.

By End User

The end-user segment of the Vietnam cardiovascular devices market includes hospitals and clinics, diagnostic laboratories, ambulatory surgical centers (ASCs), and others. Hospitals and clinics are the largest segment in terms of end users, accounting for the majority of cardiovascular device consumption. These institutions, particularly in urban areas, are typically well-equipped with the latest cardiovascular devices, allowing them to provide comprehensive diagnostic and treatment services to a broad patient base. Diagnostic laboratories also play a significant role, as they specialize in testing and diagnosing heart-related conditions through advanced diagnostic equipment. These laboratories are essential for accurate and timely diagnostics, which are critical for effective treatment plans. Ambulatory surgical centers (ASCs) are becoming increasingly important as well, as they provide cost-effective, outpatient surgical services for cardiovascular patients. These centers are equipped with the necessary surgical devices for heart-related procedures and cater to a growing number of patients seeking outpatient treatments. Other end users, such as home care providers and rehabilitation centers, are emerging as significant contributors to the market, especially as more people are diagnosed with cardiovascular conditions and seek continuous care outside traditional hospital settings.

Segments

Based on Product

Diagnostic & Monitoring Devices
Surgical Devices

Based on End User

Hospitals & Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Others

Based on Diagnostic & Monitoring Devices Type

ECG
Implantable Cardiac Monitors
Holter Monitors
Mobile Cardiac Telemetry
MRI
Others

Based on Surgical Devices Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs
Pacemakers
Coronary Stents
Catheters

Based on Region

Northern Vietnam
Central Vietnam
Southern Vietnam

Regional Analysis

Southern Vietnam (45-50%)

Southern Vietnam, particularly Ho Chi Minh City, is the dominant region in the cardiovascular devices market, accounting for approximately 45-50% of the total market share. Ho Chi Minh City, as the country’s largest and most economically developed urban center, has a well-established healthcare infrastructure with numerous private and public hospitals and specialized cardiovascular clinics. The region’s advanced healthcare facilities are equipped with state-of-the-art diagnostic and surgical cardiovascular devices, catering to both local patients and medical tourists seeking high-quality care. The growth of private healthcare providers in Southern Vietnam is a significant driver of the market, as these institutions are more likely to invest in advanced technologies. Additionally, the region benefits from a higher concentration of diagnostic laboratories and ambulatory surgical centers (ASCs), further boosting the demand for cardiovascular devices.

Northern Vietnam (30-35%)

Northern Vietnam, including the capital Hanoi, is the second-largest region in terms of market share, accounting for approximately 30-35% of the cardiovascular devices market. Hanoi, as the political and cultural hub of the country, is home to many major public healthcare institutions and universities with strong research and development capabilities in the medical field. The government’s initiatives to improve healthcare access and infrastructure are contributing to the region’s market growth. Hospitals and clinics in this region are adopting modern cardiovascular diagnostic and surgical devices, though the pace of adoption is slightly slower than in Southern Vietnam due to relatively lower healthcare spending and infrastructure limitations. However, the expanding middle class and growing healthcare awareness are expected to drive increased demand for cardiovascular technologies in this region in the coming years.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Abbott
GE HealthCare
Siemens Healthcare GmbH
BIOTRONIK SE & Co. KG
Canon Medical Systems Asia Pte. Ltd.
Cardinal Health
Medtronic
Boston Scientific Corporation
Johnson & Johnson Services, Inc
Vingroup (Vinmec)
Braun Vietnam

Competitive Analysis

The Vietnam cardiovascular devices market is characterized by the presence of leading global players such as Abbott, Medtronic, Siemens Healthcare, and Boston Scientific, alongside strong regional players like Vingroup (Vinmec). These companies dominate the market through extensive product portfolios that include diagnostic and monitoring devices, surgical tools, and therapeutic equipment. Abbott and Medtronic, for example, are renowned for their innovative cardiovascular solutions, particularly in the areas of pacemakers, stents, and defibrillators. Siemens Healthcare and GE HealthCare focus on advanced diagnostic imaging systems that are critical for early disease detection and treatment planning. In addition to multinational giants, local players like Vingroup and B.Braun Vietnam are making strides by enhancing their market presence through strategic partnerships and offering cost-effective solutions. The competition is driven by technological innovation, product quality, and strategic collaborations to cater to the growing demand for cardiovascular care across Vietnam.

Recent Developments

In February 2025, Abbott issued a safety notification for certain Assurity and Endurity pacemakers due to potential epoxy mixing issues during manufacturing, which could lead to device malfunction.

In April 2025, GE HealthCare launched the Revolution™ Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI solutions, enhancing cardiac imaging capabilities.

In April 2025, Medtronic reported promising evidence for its Affera™ pulsed field ablation technologies in treating atrial fibrillation patients.

In May 2024, Siemens Healthineers announced new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, including a new 4D transesophageal (TEE) transducer for cardiology exams.

In February 2025, Philips developed a miniaturized intracardiac transducer, enabling higher-resolution views of cardiac structures and functions, benefiting structural heart disease and electrophysiology procedures.

In March 2025, Boston Scientific announced the acquisition of SoniVie Ltd. to expand its interventional cardiology therapies offerings with ultrasound-based renal denervation technology.

In June 2024, Biovac Institute entered a partnership with Sanofi to locally manufacture inactivated polio vaccines in Africa, aiming to serve the potential needs of over 40 African countries.

Market Concentration and Characteristics

The Vietnam cardiovascular devices market is moderately concentrated, with a mix of global leaders and regional players driving competition. Key multinational companies such as Abbott, Medtronic, Siemens Healthcare, and Boston Scientific dominate the market, offering advanced and diverse product portfolios, including diagnostic, monitoring, and surgical devices. These companies benefit from strong brand recognition, extensive distribution networks, and cutting-edge technologies, which give them a competitive edge in the market. At the same time, local players like Vingroup (Vinmec) and B.Braun Vietnam are expanding their presence by providing more affordable and region-specific solutions, catering to the growing demand for cardiovascular care in both urban and rural areas. This combination of multinational and regional players creates a dynamic and competitive environment, with constant innovation and an increasing focus on meeting the needs of a diverse patient population across Vietnam.

Report Coverage

The research report offers an in-depth analysis based on Product, End User, Diagnostic & Monitoring Devices Type, Surgical Devices Type and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Vietnam cardiovascular devices market is expected to witness significant growth driven by the rising prevalence of cardiovascular diseases, leading to an increased demand for diagnostic, therapeutic, and surgical devices across the country.

Continuous advancements in cardiovascular device technologies, including minimally invasive procedures and digital health solutions, will enhance treatment efficacy and broaden the market for these devices.

Government initiatives to improve healthcare infrastructure and accessibility will create more opportunities for the adoption of advanced cardiovascular devices in both public and private healthcare settings

As health awareness continues to grow, especially concerning cardiovascular diseases, more individuals will seek early diagnosis and preventive care, leading to higher demand for diagnostic tools and monitoring devices.

The expansion of private healthcare facilities in urban areas will drive demand for advanced cardiovascular devices, particularly in cities like Ho Chi Minh City and Hanoi, where healthcare spending is increasing.

Healthcare initiatives targeting rural areas, aimed at increasing access to essential medical services, will contribute to market growth by expanding the reach of cardiovascular devices to underserved populations.

With the aging population in Vietnam, there will be a growing need for cardiovascular care, fueling demand for devices like pacemakers, defibrillators, and diagnostic imaging systems.

The growing preference for outpatient care and ambulatory surgical centers will drive the adoption of less invasive cardiovascular devices, enhancing convenience and reducing healthcare costs.

Ongoing investments in R\&D by both local and global players will lead to the development of more advanced and cost-effective cardiovascular devices, ensuring continued market innovation and growth.
Collaborations between local healthcare providers and global manufacturers will help expand the market by increasing product availability, improving quality standards, and ensuring affordability for a broader segment of the population.

CHAPTER NO. 1 : INTRODUCTION 17

1.1.1. Report Description 17

Purpose of the Report 17

USP & Key Product 17

1.1.2. Key Benefits for Stakeholders 17

1.1.3. Target Audience 18

1.1.4. Report Scope 18

CHAPTER NO. 2 : EXECUTIVE SUMMARY 19

2.1. Cardiovascular Devices Market Snapshot 19

2.1.1. Vietnam Cardiovascular Devices Market, 2018 – 2032 (USD Million) 20

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 21

3.1. Russia-Ukraine and Israel-Palestine War Impacts 21

CHAPTER NO. 4 : CARDIOVASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 22

4.1. Introduction 22

4.2. Market Drivers 23

4.2.1. Driving Factor 1 Analysis 23

4.2.2. Driving Factor 2 Analysis 24

4.3. Market Restraints 25

4.3.1. Restraining Factor Analysis 25

4.4. Market Opportunities 26

4.4.1. Market Opportunities Analysis 26

4.5. Porter’s Five Force analysis 27

4.6. Value Chain Analysis 28

4.7. Buying Criteria 29

CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 30

5.1. Company Market Share Analysis – 2023 30

5.1.1. Vietnam Cardiovascular Devices Market: Company Market Share, by Revenue, 2023 30

5.1.2. Vietnam Cardiovascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 30

5.1.3. Vietnam Cardiovascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 31

5.2. Vietnam Cardiovascular Devices Market Company Revenue Market Share, 2023 32

5.3. Company Assessment Metrics, 2023 33

5.3.1. Stars 33

5.3.2. Emerging Leaders 33

5.3.3. Pervasive Players 33

5.3.4. Participants 33

5.4. Start-ups /Code Assessment Metrics, 2023 33

5.4.1. Progressive Companies 33

5.4.2. Responsive Companies 33

5.4.3. Dynamic Companies 33

5.4.4. Starting Blocks 33

5.5. Strategic Developments 34

5.5.1. Acquisition & Mergers 34

New Product Launch 34

Regional Expansion 34

5.6. Key Players Product Matrix 35

CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 36

6.1. PESTEL 36

6.1.1. Political Factors 36

6.1.2. Economic Factors 36

6.1.3. Social Factors 36

6.1.4. Technological Factors 36

6.1.5. Environmental Factors 36

6.1.6. Legal Factors 36

6.2. Adjacent Market Analysis 36

CHAPTER NO. 7 : CARDIOVASCULAR DEVICES MARKET – BY PRODUCT SEGMENT ANALYSIS 37

7.1. Cardiovascular Devices Market Overview, by Product Segment 37

7.1.1. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

7.1.2. Cardiovascular Devices Market Attractiveness Analysis, By Product 39

7.1.3. Incremental Revenue Growth Opportunities, by Product, 2024 – 2032 39

7.1.4. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

7.2. Diagnostic & Monitoring Devices 41

7.2.1. Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

7.3. Surgical Devices 43

7.3.1. Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

7.3.2. Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

CHAPTER NO. 8 : CARDIOVASCULAR DEVICES MARKET – BY END USER SEGMENT ANALYSIS 45

8.1. Cardiovascular Devices Market Overview, by End User Segment 45

8.1.1. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

8.1.2. Cardiovascular Devices Market Attractiveness Analysis, By End User 47

8.1.3. Incremental Revenue Growth Opportunities, by End User, 2024 – 2032 47

8.1.4. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

8.2. Hospitals & Clinics 49

8.3. Diagnostic Laboratories 50

8.4. Ambulatory Surgical Centers 51

8.5. Others 52

CHAPTER NO. 9 : CARDIOVASCULAR DEVICES MARKET – VIETNAM 53

9.1. Vietnam 53

9.1.1. Key Highlights 53

9.1.2. Vietnam Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

9.2. Product 55

9.3. Vietnam Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

9.4. Vietnam Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

9.5. Diagnostic & Monitoring Device Types 56

9.5.1. Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.5.2. Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.6. Surgical Devices Types 57

9.6.1. Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.6.2. Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.7. End User 58

9.7.1. Vietnam Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

9.7.2. Vietnam Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

CHAPTER NO. 10 : COMPANY PROFILES 59

10.1. Abbott 59

10.1.1. Company Overview 59

10.1.2. Product Portfolio 59

10.1.3. Swot Analysis 59

10.1.4. Business Strategy 60

10.1.5. Financial Overview 60

10.2. GE HealthCare 61

10.3. Siemens Healthcare GmbH 61

10.4. BIOTRONIK SE & Co. KG 61

10.5. Canon Medical Systems Asia Pte. Ltd. 61

10.6. Cardinal Health 61

10.7. Medtronic 61

10.8. Boston Scientific Corporation 61

10.9. Johnson & Johnson Services, Inc 61

10.10. Vingroup (Vinmec) 61

10.11. B.Braun Vietnam 61

10.12. Company 12 61

10.13. Company 13 61

10.14. Others 61

]

List of Figures

FIG NO. 1. Vietnam Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 20

FIG NO. 2. Porter’s Five Forces Analysis for Vietnam Cardiovascular Devices Market 27

FIG NO. 3. Value Chain Analysis for Vietnam Cardiovascular Devices Market 28

FIG NO. 4. Company Share Analysis, 2023 30

FIG NO. 5. Company Share Analysis, 2023 30

FIG NO. 6. Company Share Analysis, 2023 31

FIG NO. 7. Cardiovascular Devices Market – Company Revenue Market Share, 2023 32

FIG NO. 8. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Product 39

FIG NO. 10. Incremental Revenue Growth Opportunities by Product, 2024 – 2032 39

FIG NO. 11. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

FIG NO. 12. Vietnam Cardiovascular Devices Market for Diagnostic & Monitoring Devices, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. Vietnam Cardiovascular Devices Market for Surgical Devices, Revenue (USD Million) 2018 – 2032 43

FIG NO. 14. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

FIG NO. 15. Market Attractiveness Analysis, By End User 47

FIG NO. 16. Incremental Revenue Growth Opportunities by End User, 2024 – 2032 47

FIG NO. 17. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

FIG NO. 18. Vietnam Cardiovascular Devices Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 49

FIG NO. 19. Vietnam Cardiovascular Devices Market for Diagnostic Laboratories, Revenue (USD Million) 2018 – 2032 50

FIG NO. 20. Vietnam Cardiovascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 51

FIG NO. 21. Vietnam Cardiovascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 52

FIG NO. 22. Vietnam Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 53

List of Tables

TABLE NO. 1. : Vietnam Cardiovascular Devices Market: Snapshot 19

TABLE NO. 2. : Drivers for the Cardiovascular Devices Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the Cardiovascular Devices Market: Impact Analysis 25

TABLE NO. 4. : Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 5. : Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 6. : Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 7. : Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 8. : Vietnam Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

TABLE NO. 9. : Vietnam Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 54

TABLE NO. 10. : Vietnam Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

TABLE NO. 11. : Vietnam Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

TABLE NO. 12. : Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 13. : Vietnam Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 14. : Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 15. : Vietnam Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 16. : Vietnam Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

TABLE NO. 17. : Vietnam Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

Frequently Asked Questions

What is the current market size of the Vietnam Cardiovascular Devices Market?

The Vietnam Cardiovascular Devices Market is projected to reach USD202.06 million in 2024 and is estimated to grow to USD395.32 million by 2032, reflecting significant market expansion over the forecast period.

What is the expected compound annual growth rate (CAGR) of the Vietnam Cardiovascular Devices Market?

The market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032, driven by increasing healthcare investments and the growing burden of cardiovascular diseases.

Who are the key players in the Vietnam Cardiovascular Devices Market?

Prominent companies such as Philips Healthcare, GE Healthcare, and Medtronic are significant contributors to the market, offering advanced cardiovascular solutions in Vietnam.

How is urbanization influencing the cardiovascular devices market in Vietnam?

Urbanization is driving demand for advanced healthcare services, including cardiovascular devices, as urban areas have better access to medical technology and healthcare infrastructure.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –